BACKGROUND.
Medulloblastoma is one of the most frequent malignant 
MATERIALS AND METHODS.
A 22 month-old female diagnosed with medulloblastoma underwent intensive chemotherapy. The regimen was three two-month courses of chemotherapy with methotrexate and other anti cancer agents. The patient has received one complete course to date.
Methotrexate CSF samples were drawn before the first intraventricular injection and a 24-h after each intraventricular administration.
CSF methotrexate nevels were determined by FPIA using an Abbot TDX analyzer. Values on day 1 of each cycle were obtained prior to the intraventricular injection; therefore, day 1 values were not considered in the calculation of the mean CSF concentration.
RESULTS
Values on days 1 and 2 of week 1 were excluded from our analysis because the corresponding samples were contaminated.
CONCLUSION
FPIA proved to be a reliable method to measure CSF fluid methotrexate concentrations, within published ranges, although further studies are required to verify these findings.
